J Am Chem Soc. 2021 Feb 10;143(5):2194-2199. doi: 10.1021/jacs.0c12330. Epub 2021 Feb 2.
Zinc-phthalocyanine (ZnPc) photosensitizers (PSs) have shown great potential in photodynamic therapy (PDT) owing to their strong absorption at long wavelengths (650-750 nm), high triplet quantum yields, and biocompatibility. However, the clinical utility of ZnPc PSs is limited by their poor solubility and tendency to aggregate in aqueous environments. Here we report the design of a new nanoscale metal-organic layer (nMOL) assembly, ZnOPPc@nMOL, with ZnOPPc [ZnOPPc = zinc(II)-2,3,9,10,16,17,23,24-octa(4-carboxyphenyl)phthalocyanine] PSs supported on the secondary building units (SBUs) of a Hf nMOL for PDT. Upon irradiation, SBU-bound ZnOPPc PSs absorb 700 nm light and efficiently sensitize the formation of singlet oxygen by preventing aggregation-induced self-quenching of ZnOPPc excited states. With intrinsic mitochondria-targeting capability, ZnOPPc@nMOL showed exceptional PDT efficacy with >99% tumor growth inhibition and 40-60% cure rates on two mouse models of colon cancer.
锌酞菁(ZnPc)光敏剂(PSs)因其在长波长(650-750nm)处的强吸收、高三重态量子产率和生物相容性,在光动力疗法(PDT)中显示出巨大的潜力。然而,ZnPc PSs 的临床应用受到其在水相环境中较差的溶解度和聚集倾向的限制。在此,我们报告了一种新型纳米级金属有机层(nMOL)组装体 ZnOPPc@nMOL 的设计,其中 ZnOPPc [ZnOPPc=锌(II)-2,3,9,10,16,17,23,24-八(4-羧基苯基)酞菁] PSs 负载在 Hf nMOL 的次级构筑单元(SBU)上,用于 PDT。在照射下,SBU 结合的 ZnOPPc PSs 吸收 700nm 光,并通过防止 ZnOPPc 激发态的聚集诱导自猝灭,有效地敏化单线态氧的形成。由于具有内在的线粒体靶向能力,ZnOPPc@nMOL 在两种结肠癌小鼠模型中表现出优异的 PDT 疗效,肿瘤生长抑制率超过 99%,治愈率为 40-60%。